<DOC>
	<DOCNO>NCT01694927</DOCNO>
	<brief_summary>The aim study evaluate use autologous expand mesenchymal stem cell intralesional transplantation safe potentially beneficial treatment patient spinal cord injury .</brief_summary>
	<brief_title>Autologous Mesenchymal Stem Cells Spinal Cord Injury ( SCI ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>American Spinal Injury Association Impairment ( ASIA ) Scale A , B C Cervical ( C4 ) , thoracic lumbar spine lesion Complete Incomplete SCI Platelet count 100.000/ul Acute SCI ( less 3 month ) Active infectious disease Pregnancy Neurodegenerative diseases Primary hematologic diseases Coagulopathies Hepatic dysfunction Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Mesenchymal stem cell</keyword>
	<keyword>Spinal cord injury</keyword>
</DOC>